Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis
Funding sources: none.
Conflicts of interest: R.B.W. has acted as a consultant, speaker and/or had funding support for research from Abbott, Janssen, Pfizer and MSD, all of whom manufacture biological agents. C.E.M.G. has acted as a speaker and consultant for Abbott, Pfizer, Leo, Janssen, Novartis and MSD.
No abstract is available for this article.